| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 302 | 2021 |
| The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia D Brusa, S Serra, M Coscia, D Rossi, G D’Arena, L Laurenti, O Jaksic, ... haematologica 98 (6), 953, 2013 | 299 | 2013 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus L Scarfò, T Chatzikonstantinou, GM Rigolin, G Quaresmini, M Motta, ... Leukemia 34 (9), 2354-2363, 2020 | 286 | 2020 |
| Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA … AC Rawstron, KA Kreuzer, A Soosapilla, M Spacek, O Stehlikova, ... Cytometry Part B: Clinical Cytometry 94 (1), 121-128, 2018 | 260 | 2018 |
| Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ... Bone marrow transplantation 49 (7), 865-872, 2014 | 253 | 2014 |
| CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential S Deaglio, T Vaisitti, S Aydin, L Bergui, G D'Arena, L Bonello, P Omedé, ... Blood, The Journal of the American Society of Hematology 110 (12), 4012-4021, 2007 | 247 | 2007 |
| Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia F Arruga, B Gizdic, S Serra, T Vaisitti, C Ciardullo, M Coscia, L Laurenti, ... Leukemia 28 (5), 1060-1070, 2014 | 150 | 2014 |
| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 95 | 2021 |
| COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA L Pagano, J Salmanton-García, F Marchesi, A López-García, S Lamure, ... Blood, The Journal of the American Society of Hematology 139 (10), 1588-1592, 2022 | 91 | 2022 |
| Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography J Vincelj, I Sokol, O Jakšić Echocardiography 19 (4), 319-324, 2002 | 88 | 2002 |
| European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European … K Hübel, MM Fresen, JF Apperley, GW Basak, KW Douglas, IH Gabriel, ... Bone marrow transplantation 47 (8), 1046-1050, 2012 | 80 | 2012 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 78 | 2022 |
| More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML) R Kusec, O Jaksic, S Ostojic, I Kardum-Skelin, R Vrhovac, B Jaksic Blood 108 (1), 405-406, 2006 | 74 | 2006 |
| CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow O Jaksic, MM Kardum Paro, I Kardum Skelin, R Kusec, V Pejsa, B Jaksic Blood 103 (5), 1968-1969, 2004 | 67 | 2004 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 65 | 2022 |
| Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment S Serra, T Vaisitti, V Audrito, C Bologna, R Buonincontri, SS Chen, ... Blood advances 1 (1), 47-61, 2016 | 58 | 2016 |
| Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide F Malard, N Kröger, IH Gabriel, K Hübel, JF Apperley, GW Basak, ... Biology of blood and marrow transplantation 18 (2), 314-317, 2012 | 57 | 2012 |
| BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib S Bonfiglio, LA Sutton, V Ljungström, A Capasso, T Pandzic, S Weström, ... Blood advances 7 (12), 2794-2806, 2023 | 54 | 2023 |
| Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009 I Novak, O Jakšić, T Kuliš, K Batinjan, A Znaor Croatian medical journal 53 (2), 115-123, 2012 | 48 | 2012 |
| Haematopoietic stem cell mobilization with plerixafor and G‐CSF in patients with multiple myeloma transplanted with autologous stem cells GW Basak, O Jaksic, Z Koristek, G Mikala, S Basic‐Kinda, J Mayer, ... European journal of haematology 86 (6), 488-495, 2011 | 46 | 2011 |
